INFOTHEK
Events
ERKNet/ERA Webinar: ADTKD
12th November 2024,
Jan Halbritter, Charité – Universitätsmedizin Berlin
International ADTKD Summit: News on ADTKD
7th-8th October 2022
Day 1: Scientific program
Day 2: Patient day
ERA e-seminar 2022: Genetics and CKD: how common is it? When should we think about it?
ADTKD-MUC1 Update July 2022 (Wake Forest School of Medicine)
ORGANISATIONS IN GERMANY
Centers for rare kidney diseases in Germany
CeRKiD Berlin - Charité University Medicine
Hannover Medical School - Center for Rare Diseases (Congenital Kidney Diseases)
University Hospital Düsseldorf - Outpatient Clinic for Rare and Hereditary Kidney Diseases
Zentrum für seltene Nierenerkrankungen am Universitätsklinikum Leipzig
Further Contacts
SE-ATLAS – Care Atlas for People with Rare Diseases
Young Kidney Patients Germany e.V.
German Kidney Foundation
DIATRA - Journal for chronically ill people in the fields of nephrology, transplantation, and diabetology
Young Heroes - Association that educates people throughout Germany about organ donation
ProTransplant - Alliance of patient associations in the field of transplantation & organ donation
Crossover-nierenspenderliste.de – Mediation of crossover living kidney donations
https://crossover-nierenspenderliste.de
Organ donation - Portal of the Federal Center for Health Education (BZgA)
https://www.organspende-info.de
Transdia-Sport Germany e.V.
ORGANISATIOS IN EUROPE
European reference work for rare kidney diseases
European Chronic Kidney Disease Alliance (EKHA)
Orphanet – Portal for rare diseases and orphan drugs
EKPF - European Kidney Patients' Federation
ORGANISATIONS IN THE USA
Rare Kidney Disease Foundation - Patient organisation for ADTKD
NORD – Organisation for people with rare diseases in the USA
GARD – Genetic and Rare Diseases Information Center of the National Instituts of Health in the USA
LITERATUR FOR EXPERTS
Xiao L et al. Molecular basis of TMED9 oligomerization and entrapment of misfolded protein cargo in the early secretory pathway.
Sci Adv. 2024 Sep 20;10(38):eadp2221.https://pubmed.ncbi.nlm.nih.gov/39303030
Econimo L et al. Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD. Kidney Int Rep. 2022 Aug 29;7(11):2332-2344.
https://pubmed.ncbi.nlm.nih.gov/36531871
Wopperer FJ et al. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney Int. 2022;102(2):405-420.
https://pubmed.ncbi.nlm.nih.gov/35643372
Popp B et al. Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study. Eur J Hum Genet. 2022 Sep 13. doi: 10.1038/s41431-022-01177-9. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov
Mabillard H, et al. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrol Dial Transplant. 2021 Sep 14;gfab268.
https://pubmed.ncbi.nlm.nih.gov/34519781
Dvela-Levitt M, et al. A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies. Trends Mol Med. 2021 Apr;27(4):394-409.
https://pubmed.ncbi.nlm.nih.gov/33341352
Olinger E, et al. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1 Kidney Int. 2020 Sep;98(3):717-731.
https://pubmed.ncbi.nlm.nih.gov/32450155
Bleyer AJ, et al. Quality of life in patients with autosomal dominant tubulointerstitial kidney disease. Clin Nephrol. 2019 Dec;92(6):302-311.
https://pubmed.ncbi.nlm.nih.gov/31587753
Knaup, KX, Wiesener, MS. Autosomal-dominante tubulointerstitielle Nierenerkrankungen (ADTKD). Nephrologe 2019;14: 112–119.
https://www.springermedizin.de/der-nephrologe-2-2019/16513674
Bleyer AJ, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019 Sep 5;5(1):60. https://pubmed.ncbi.nlm.nih.gov/31488840
Dvela-Levitt M, et al. Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy. Cell. 2019 Jul 25;178(3):521-535.e23.
https://pubmed.ncbi.nlm.nih.gov/31348885
Knaup KX, et al. Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition. J Am Soc Nephrol. 2018 Sep;29(9):2298-2309.
https://pubmed.ncbi.nlm.nih.gov/30049680
Žvirna M, et al. Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease. J Am Soc Nephrol. 2018 Sep;29(9):2418-2431
https://pubmed.ncbi.nlm.nih.gov/29967284
Eckardt KU, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney Int. 2015 Oct;88(4):676-83.
https://pubmed.ncbi.nlm.nih.gov/25738250
Ekici AB, et al. Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney Int. 2014 Sep;86(3):589-99
https://pubmed.ncbi.nlm.nih.gov/24670410
Bleyer AJ, et al. Autosomal dominant tubulointerstitial kidney disease: of names and genes. Kidney Int. 2014 Sep;86(3):459-61. https://pubmed.ncbi.nlm.nih.gov/25168494
Bernascone I, et al. A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. Hum Mol Genet. 2010 Aug 1;19(15):2998-3010
https://pubmed.ncbi.nlm.nih.gov/20472742